<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Biotech on Tenu Tech Brief</title>
    <link>https://cluster-site.onrender.com/tags/biotech/</link>
    <description>Recent content in Biotech on Tenu Tech Brief</description>
    <generator>Hugo -- 0.146.0</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 24 Feb 2026 06:05:13 +0000</lastBuildDate>
    <atom:link href="https://cluster-site.onrender.com/tags/biotech/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Biotech investor set to lead US National Science Foundation</title>
      <link>https://cluster-site.onrender.com/posts/biotech-investor-set-to-lead-us-national-science-foundation/</link>
      <pubDate>Mon, 23 Feb 2026 00:39:40 +0000</pubDate>
      <guid>https://cluster-site.onrender.com/posts/biotech-investor-set-to-lead-us-national-science-foundation/</guid>
      <description>• Email Bluesky Facebook LinkedIn Reddit Whatsapp X Jim O&amp;rsquo;Neill, a biotechnology investor who has held other positions in government, will be appointed by US President Donald Trump</description>
    </item>
    <item>
      <title>Biotech investor set to lead US National Science Foundation</title>
      <link>https://cluster-site.onrender.com/posts/biotech-investor-set-to-lead-us-national-science-foundation/</link>
      <pubDate>Sun, 22 Feb 2026 00:39:57 +0000</pubDate>
      <guid>https://cluster-site.onrender.com/posts/biotech-investor-set-to-lead-us-national-science-foundation/</guid>
      <description>• Email Bluesky Facebook LinkedIn Reddit Whatsapp X Jim O&amp;rsquo;Neill, a biotechnology investor who has held other positions in government, will be appointed by US President Donald Trump</description>
    </item>
    <item>
      <title>Biotech Startup M&amp;A Is Reliably Delivering Some Big Exits</title>
      <link>https://cluster-site.onrender.com/posts/biotech-startup-ma-is-reliably-delivering-some-big-exits/</link>
      <pubDate>Wed, 18 Feb 2026 12:00:33 +0000</pubDate>
      <guid>https://cluster-site.onrender.com/posts/biotech-startup-ma-is-reliably-delivering-some-big-exits/</guid>
      <description>• Over past two years, biotech M&amp;amp;A exceeded $38B, surpassing many historic tech exits. • 2026 kickoff: Eli Lilly to pay up to $2.4B for Orna Therapeutics, boosting in‑vivo cell the</description>
    </item>
    <item>
      <title>Rhododendron-derived drugs now made by bacteria</title>
      <link>https://cluster-site.onrender.com/posts/rhododendron-derived-drugs-now-made-by-bacteria/</link>
      <pubDate>Tue, 17 Feb 2026 22:50:05 +0000</pubDate>
      <guid>https://cluster-site.onrender.com/posts/rhododendron-derived-drugs-now-made-by-bacteria/</guid>
      <description>• E. coli engineered to synthesize rhododendron-derived compounds with anticancer, anti-HIV, antidiabetic, anti-inflammatory properties. • Kobe University&amp;rsquo;s rational design strateg</description>
    </item>
  </channel>
</rss>
